Sembolic 15mg Injection – Semaglutide 15mg/3mL

Sembolic 15mg/3mL Injection contains semaglutide, a GLP-1 receptor agonist used as part of medical management for eligible adults. Sembolic is marketed by Torrent Pharmaceuticals and is supplied as a 15mg/3mL injectable formulation.

For South African pharmaceutical buyers, healthcare professionals and licensed medicine distributors, product sourcing should always take account of applicable SAHPRA requirements, prescription controls, import rules and the legal supply chain. SAHPRA advises that medicines containing semaglutide should be obtained through legitimate, licensed channels and that the regulatory status of a particular product should be verified before supply or use.

Sembolic 15mg/3mL Product Information

Brand: Sembolic

Active ingredient: Semaglutide

Strength: 15mg/3mL

Dosage form: Injection

Manufacturer/marketer: Torrent Pharmaceuticals

Route: Subcutaneous administration

Product category: GLP-1 receptor agonist

Storage: Follow the product packaging and approved prescribing information for storage requirements.

The 15mg/3mL formulation is designed for use with the appropriate reusable delivery device. The dosage and treatment schedule should be determined by a qualified healthcare professional according to the approved product information and the individual patient's clinical requirements.

How Sembolic Works

Semaglutide acts on GLP-1 receptors involved in glucose regulation and appetite signalling. It can support glucose-dependent insulin secretion and reduce glucagon secretion when blood glucose is elevated. It also delays gastric emptying and can influence appetite and food intake.

Sembolic should not be presented as a substitute for medical assessment. Treatment decisions, dose adjustments and continued use should be made by the prescribing healthcare professional.

Important Safety Information

Semaglutide medicines can cause gastrointestinal adverse effects such as nausea, vomiting, diarrhoea, abdominal discomfort and constipation. Other clinically important adverse reactions and warnings are described in the manufacturer's prescribing information.

Patients should inform their healthcare professional about existing medical conditions and other medicines they use before treatment. The product should be used according to professional medical advice and the approved product information.

Sembolic 15mg Injection for South Africa

Global pharmaceutical sourcing for South Africa requires attention to product authenticity, documentation, cold-chain handling where applicable, import requirements and the local regulatory framework. SAHPRA has specifically warned against unregistered, falsified and unauthorised GLP-1 products and recommends obtaining medicines through legitimate supply channels.

Frequently Asked Questions

What is Sembolic 15mg Injection?

Sembolic 15mg/3mL is a semaglutide injection marketed by Torrent Pharmaceuticals. It belongs to the GLP-1 receptor agonist class.

Is Sembolic 15mg/3mL available for South African buyers?

Availability and lawful importation depend on the applicable South African regulatory and import requirements. Buyers should verify the product's current regulatory status before placing an order.

How is Sembolic administered?

It is administered by subcutaneous injection. The appropriate dose and administration schedule should be determined by a qualified healthcare professional.

How should Sembolic be stored?

Storage should follow the manufacturer's current product information and packaging instructions. Appropriate temperature control should be maintained throughout pharmaceutical handling and transportation.

Can I order Sembolic 15mg for export?

Qualified pharmaceutical buyers can contact the exporter for availability, quotation, documentation and shipping information. Any import or distribution must comply with South African requirements and applicable regulations.